Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancer
Phase of Trial: Phase I/II
Latest Information Update: 08 Sep 2017
Price : $35 *
At a glance
- Drugs Cisplatin; Docetaxel; Gimeracil/oteracil/tegafur
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2017 Status changed from active, no longer recruiting to completed.
- 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Sep 2013 New trial record